{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:02Z","timestamp":1786980122020,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00408-019-00222-7","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T02:02:41Z","timestamp":1554688961000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Analysis"],"prefix":"10.1007","volume":"197","author":[{"given":"Charlotte","family":"Berlier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther I.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Saxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Lichtblau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"1","key":"222_CR1","first-page":"67","volume":"37","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A et al (2015) 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 37(1):67\u2013119","journal-title":"Eur Respir J"},{"issue":"S01","key":"222_CR2","first-page":"S62","volume":"141","author":"H Wilkens","year":"2016","unstructured":"Wilkens H, Konstantinides S, Lang I, Bunck AC, Gerges M, Gerhardt F et al (2016) Chronic thromboembolic pulmonary hypertension: recommendations of the Cologne Consensus Conference 2016. Dtsch Med Wochenschr 141(S01):S62\u2013S69","journal-title":"Dtsch Med Wochenschr"},{"issue":"3","key":"222_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1378\/chest.130.3.841","volume":"130","author":"S Ulrich","year":"2006","unstructured":"Ulrich S, Fischler M, Speich R, Popov V, Maggiorini M (2006) Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest 130(3):841\u2013846","journal-title":"Chest"},{"issue":"4","key":"222_CR4","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1183\/09031936.06.00130405","volume":"28","author":"E Cenedese","year":"2006","unstructured":"Cenedese E, Speich R, Dorschner L, Ulrich S, Maggiorini M, Jenni R et al (2006) Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 28(4):808\u2013815","journal-title":"Eur Respir J"},{"issue":"5","key":"222_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1055\/s-0033-1355442","volume":"34","author":"JE Cannon","year":"2013","unstructured":"Cannon JE, Pepke-Zaba J (2013) Is distal chronic thromboembolic pulmonary hypertension treatable with PAH targeted drugs? Semin Respir Crit Care Med 34(5):620\u2013626","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"222_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ccl.2004.04.010","volume":"22","author":"NF Voelkel","year":"2004","unstructured":"Voelkel NF, Cool C (2004) Pathology of pulmonary hypertension. Cardiol Clin 22(3):343\u2013351","journal-title":"Cardiol Clin"},{"issue":"9","key":"222_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1056\/NEJMoa1413687","volume":"373","author":"N Galie","year":"2015","unstructured":"Galie N, Barbera JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV et al (2015) Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 373(9):834\u2013844","journal-title":"N Engl J Med"},{"issue":"5","key":"222_CR8","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1183\/09031936.00105914","volume":"45","author":"N Galie","year":"2015","unstructured":"Galie N, Muller K, Scalise AV, Grunig E (2015) PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension. Eur Respir J 45(5):1314\u20131322","journal-title":"Eur Respir J"},{"issue":"9","key":"222_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1213917","volume":"369","author":"T Pulido","year":"2013","unstructured":"Pulido T, Adzerikho I, Channick RN, Delcroix M, Galie N, Ghofrani HA et al (2013) Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 369(9):809\u2013818","journal-title":"N Engl J Med"},{"issue":"1","key":"222_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000488000","volume":"96","author":"P Bartenstein","year":"2018","unstructured":"Bartenstein P, Saxer S, Appenzeller P, Lichtblau M, Schwarz EI, Ulrich S (2018) Risk factor profiles achieved with medical therapy in prevalent patients with pulmonary arterial and distal chronic thromboembolic pulmonary hypertension. Respiration 96(1):127\u2013137","journal-title":"Respiration"},{"issue":"6","key":"222_CR11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1183\/13993003.02043-2015","volume":"47","author":"O Sitbon","year":"2016","unstructured":"Sitbon O, Sattler C, Bertoletti L, Savale L, Cottin V, Jais X et al (2016) Initial dual oral combination therapy in pulmonary arterial hypertension. Eur Respir J 47(6):1727\u20131736","journal-title":"Eur Respir J"},{"issue":"4","key":"222_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1056\/NEJMoa1209655","volume":"369","author":"HA Ghofrani","year":"2013","unstructured":"Ghofrani HA, Galie N, Grimminger F, Grunig E, Humbert M, Jing ZC et al (2013) Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med 369(4):330\u2013340","journal-title":"N Engl J Med"},{"issue":"4","key":"222_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1183\/09031936.00137511","volume":"40","author":"G Simonneau","year":"2012","unstructured":"Simonneau G, Torbicki A, Hoeper MM, Delcroix M, Karlocai K, Galie N et al (2012) Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension. Eur Respir J 40(4):874\u2013880","journal-title":"Eur Respir J"},{"issue":"26","key":"222_CR14","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","volume":"373","author":"O Sitbon","year":"2015","unstructured":"Sitbon O, Channick R, Chin KM, Frey A, Gaine S, Galie N et al (2015) Selexipag for the treatment of pulmonary arterial hypertension. N Engl J Med 373(26):2522\u20132533","journal-title":"N Engl J Med"},{"issue":"2","key":"222_CR15","doi-asserted-by":"publisher","first-page":"1602493","DOI":"10.1183\/13993003.02493-2016","volume":"50","author":"S Gaine","year":"2017","unstructured":"Gaine S, Chin K, Coghlan G, Channick R, Di Scala L, Galie N et al (2017) Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension. Eur Respir J 50(2):1602493","journal-title":"Eur Respir J"},{"issue":"2","key":"222_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1159\/000370125","volume":"89","author":"S Mueller-Mottet","year":"2015","unstructured":"Mueller-Mottet S, Stricker H, Domenighetti G, Azzola A, Geiser T, Schwerzmann M et al (2015) Long-term data from the Swiss pulmonary hypertension registry. Respiration. 89(2):127\u2013140","journal-title":"Respiration."},{"issue":"18","key":"222_CR17","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1161\/CIRCULATIONAHA.110.015008","volume":"124","author":"J Pepke-Zaba","year":"2011","unstructured":"Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D et al (2011) Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation 124(18):1973\u20131981","journal-title":"Circulation"},{"issue":"4","key":"222_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/ejechocard\/jen174","volume":"9","author":"A Evangelista","year":"2008","unstructured":"Evangelista A, Flachskampf F, Lancellotti P, Badano L, Aguilar R, Monaghan M et al (2008) European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr 9(4):438\u2013448","journal-title":"Eur J Echocardiogr"},{"issue":"47","key":"222_CR19","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1093\/eurheartj\/ehx257","volume":"39","author":"D Kylhammar","year":"2017","unstructured":"Kylhammar D, Kjellstrom B, Hjalmarsson C, Jansson K, Nisell M, Soderberg S et al (2017) A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. Eur Heart J 39(47):4175\u20134181","journal-title":"Eur Heart J"},{"issue":"2","key":"222_CR20","doi-asserted-by":"publisher","first-page":"1700889","DOI":"10.1183\/13993003.00889-2017","volume":"50","author":"A Boucly","year":"2017","unstructured":"Boucly A, Weatherald J, Savale L, Jais X, Cottin V, Prevot G et al (2017) Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J 50(2):1700889","journal-title":"Eur Respir J"},{"issue":"2","key":"222_CR21","doi-asserted-by":"publisher","first-page":"1700740","DOI":"10.1183\/13993003.00740-2017","volume":"50","author":"MM Hoeper","year":"2017","unstructured":"Hoeper MM, Kramer T, Pan Z, Eichstaedt CA, Spiesshoefer J, Benjamin N et al (2017) Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model. Eur Respir J 50(2):1700740","journal-title":"Eur Respir J"},{"issue":"1","key":"222_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40256-017-0262-z","volume":"18","author":"JG Coghlan","year":"2018","unstructured":"Coghlan JG, Channick R, Chin K, Di Scala L, Galie N, Ghofrani HA et al (2018) Targeting the prostacyclin pathway with selexipag in patients with pulmonary arterial hypertension receiving double combination therapy: insights from the randomized controlled GRIPHON study. Am J Cardiovasc Drugs 18(1):37\u201347","journal-title":"Am J Cardiovasc Drugs"},{"issue":"25 Suppl","key":"222_CR23","doi-asserted-by":"publisher","first-page":"D73","DOI":"10.1016\/j.jacc.2013.10.034","volume":"62","author":"VV McLaughlin","year":"2013","unstructured":"McLaughlin VV, Gaine SP, Howard LS, Leuchte HH, Mathier MA, Mehta S et al (2013) Treatment goals of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D73\u2013D81","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"222_CR24","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1183\/09031936.00217911","volume":"40","author":"G Deboeck","year":"2012","unstructured":"Deboeck G, Scoditti C, Huez S, Vachiery JL, Lamotte M, Sharples L et al (2012) Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension. Eur Respir J 40(6):1410\u20131419","journal-title":"Eur Respir J"},{"issue":"1","key":"222_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11136-005-3513-4","volume":"15","author":"SP McKenna","year":"2006","unstructured":"McKenna SP, Doughty N, Meads DM, Doward LC, Pepke-Zaba J (2006) The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual Life Res 15(1):103\u2013115","journal-title":"Qual Life Res"},{"issue":"1","key":"222_CR26","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1477-7525-10-110","volume":"10","author":"K Cima","year":"2012","unstructured":"Cima K, Twiss J, Speich R, McKenna SP, Grunig E, Kahler CM et al (2012) The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR). Health Qual Life Outcomes 10(1):110","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"222_CR27","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1183\/09031936.00069708","volume":"32","author":"DM Meads","year":"2008","unstructured":"Meads DM, McKenna SP, Doughty N, Das C, Gin-Sing W, Langley J et al (2008) The responsiveness and validity of the CAMPHOR utility index. Eur Respir J 32(6):1513\u20131519","journal-title":"Eur Respir J"},{"issue":"1","key":"222_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R (1996) EuroQol: the current state of play. Health Policy 37(1):53\u201372","journal-title":"Health Policy"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00222-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00408-019-00222-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-019-00222-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T19:18:32Z","timestamp":1586200712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00408-019-00222-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1007\/s00408-019-00222-7","relation":{},"ISSN":["0341-2040","1432-1750"],"issn-type":[{"value":"0341-2040","type":"print"},{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"25 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None of the authors declares any conflict of interest in relation to the present work. SU received grant money from the Swiss National Science Foundation, Zurich Lung, Actelion SA, Bayer SA, Orpha Swiss. SU; EIS, SS, ML and CB received travel support and lecture fees from Actelion SA, Bayer SA, MSD SA and Orpha Swiss.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This retrospective cohort study complied with the ethical laws in Switzerland and all patients have signed informed consent for the Zurich PH cohort study (KEK 2014-0214).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}